Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice. - Wikidata - awgldk - TriplyDB

Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.

Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.

http://www.wikidata.org/entity/Q53426697

about

Glycyrrhizic acid in the treatment of liver diseases: literature review Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats Terpenoids as potential chemopreventive and therapeutic agents in liver cancer Effect of the extracts from Glycyrrhiza uralensis Fisch on the growth characteristics of human cell lines: Anti-tumor and immune activation activities.Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats.Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.Hepatoprotective Activity of Licorice Water Extract against Cadmium-induced Toxicity in Rats p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release.Experimental mouse models for hepatocellular carcinoma research.The anti-angiogenic activities of glycyrrhizic acid in tumor progression.Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in rats.Null anticarcinogenic effect of silymarin on diethylnitrosamine-induced hepatocarcinogenesis in rats 5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.18β-glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell-mediated immunosuppression in mice.Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review.Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.A green and efficient protocol for large-scale production of glycyrrhizic acid from licorice roots by combination of polyamide and macroporous resin adsorbent chromatography.Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet.

P2860

Q26851465-E53CD78A-B39B-461B-AAEC-8E2399CC35C4 Q26853520-4DE5A83F-F1A5-495D-B3AA-2D06C44D19D8 Q34114265-862786DE-70BC-4536-829E-E1C47FB2078F Q34606453-DB19BA89-7564-4EE3-83EC-15BB2A133D16 Q35238085-4252619C-46E5-4A44-A6A7-850E4213848B Q36255525-703AF42F-FEB6-4F15-9365-816A7F2E8F9A Q36397276-9ADAA945-D444-46B6-9E62-C1CEBFCE4346 Q36909491-BF2F1711-8CA3-43B4-82A5-CFFDCAC56027 Q37028411-5515A4A7-A27D-4C7D-BE00-A8D17DDD4AD6 Q37148781-46914FBE-5E9B-4312-9C56-6A6E135CCCD9 Q37202868-C3238D92-1E62-43B3-B6A0-BE9F526D378B Q37247096-A2F33CDF-B274-4CBE-9051-693853BCB05F Q37574072-B1F4C423-66A0-4A18-9E5D-378145663129 Q39296184-74AB25CE-3923-4950-A7B1-73EB2304DEF8 Q39554423-F00EE6F2-1328-487A-B4A8-723F69E48F2B Q41918847-E0C67281-FD06-4860-A37C-1FD5623E7C41 Q42673174-1D377E22-DD96-484F-A9DF-F1EEE75DEADC Q44044385-66CE515A-E67F-45F3-A503-2BA3A15A6378 Q47196712-77658EBD-9A9C-4D92-A007-5957972A8DB2 Q50335864-14F037E8-60AE-4911-895E-A8A5BEA00B3C Q50484804-E2AF903E-C401-46D5-901C-91885C41F8B8 Q50534138-EE78142C-A1E1-4FFF-9CA8-1EB20980AD8E

P2860

Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.

http://www.wikidata.org/entity/Q53426697

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@en

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@nl

type

label

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@en

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@nl

prefLabel

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@en

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@nl

P1433

Q53426697-FFAA4B89-3FE4-4394-96CC-92742D7F1ABA

P1476

Q53426697-41382349-3CF2-4F61-9D74-12A00F22696E

P2093

Q53426697-0605F97C-AC54-4C2A-92BB-C646D7665360

Q53426697-0B8988D9-2001-41A4-9E30-73A020BF2C79

Q53426697-1448ABC7-502F-44B2-9527-EF375758A34B

Q53426697-5A3DD274-CF53-47F2-A487-6C50FD9F22D3

Q53426697-699CE7EE-D7A9-46B3-92FB-C1BD3C89B48C

Q53426697-853BCB07-FAB8-43C0-8367-47FDF68718F7

Q53426697-A12094DE-6713-48CE-AF59-BF12E8BCE8FE

Q53426697-CAF45F24-40AA-41B2-925C-A08ED6EC0C2B

P2860

Q53426697-150BCAC7-5F63-4A10-8D28-DD57961AA33E

Q53426697-3C22DDCC-65B7-46E5-AED5-8120C9D62270

Q53426697-56723EBA-6E55-4E85-94AF-5413E08E49CC

Q53426697-59096049-3FDD-45CE-8924-77BBB772BCDA

Q53426697-9D4F1558-9500-4659-B22D-F511F484124E

Q53426697-AAB2CCF2-A663-40A3-B508-20CCA51340FC

Q53426697-B13E8D6A-4AAA-4B68-84D9-8DA2FC328280

Q53426697-F3E2560A-3062-45A2-9AE7-11BC49880195

P304

Q53426697-7C1520FF-CDF0-470F-AE30-FB293F259491

P31

Q53426697-40A5105A-9C3B-4C84-8F0D-708EBA78C7E8

P356

Q53426697-99F93E24-7564-4D4C-A3CB-D75A982B9CAD

P407

Q53426697-13601114-CC8C-41B7-BEC7-2CDA38A12B8B

P433

Q53426697-CF7A1B8A-4B9E-47C6-B5AD-DDF617B38EE5

P478

Q53426697-C4D2DF2C-2C5F-460C-84D5-3A6A4505FF19

P577

Q53426697-6327FFD6-A866-4FEC-97B3-FA9B5381174A

P5875

Q53426697-A61E66F3-8EB4-40A7-BB2D-18C808DCD6B6

P698

Q53426697-733C1B10-1CFB-4523-AF75-C7752E478168

P356

P1433

P1476

Inhibition of hepatocellular c ...... ethylnitrosamine-treated mice.

@en

P2093

Harada K

http://www.w3.org/2001/XMLSchema#string

Ishida M

http://www.w3.org/2001/XMLSchema#string

Ito H

http://www.w3.org/2001/XMLSchema#string

Katayama S

http://www.w3.org/2001/XMLSchema#string

Kawasaki H

http://www.w3.org/2001/XMLSchema#string

Okubo M

http://www.w3.org/2001/XMLSchema#string

Shiota G

http://www.w3.org/2001/XMLSchema#string

Tomie Y

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro

Glycyrrhizic acid inhibits virus growth and inactivates virus particles.

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

The antiviral activity against herpes simplex virus of the triterpenoid compounds carbenoxolone sodium and cicloxolone sodium.

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

P304

59-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/20.1.59

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273033964

http://www.w3.org/2001/XMLSchema#string

P698

9934850

http://www.w3.org/2001/XMLSchema#string